| Literature DB >> 23677421 |
T Bender1, G Bálint, Z Prohászka, P Géher, I K Tefner.
Abstract
Balneotherapy is appreciated as a traditional treatment modality in medicine. Hungary is rich in thermal mineral waters. Balneotherapy has been in extensive use for centuries and its effects have been studied in detail. Here, we present a systematic review and meta-analysis of clinical trials conducted with Hungarian thermal mineral waters, the findings of which have been published by Hungarian authors in English. The 122 studies identified in different databases include 18 clinical trials. Five of these evaluated the effect of hydro- and balneotherapy on chronic low back pain, four on osteoarthritis of the knee, and two on osteoarthritis of the hand. One of the remaining seven trials evaluated balneotherapy in chronic inflammatory pelvic diseases, while six studies explored its effect on various laboratory parameters. Out of the 18 studies, 9 met the predefined criteria for meta-analysis. The results confirmed the beneficial effect of balneotherapy on pain with weight bearing and at rest in patients with degenerative joint and spinal diseases. A similar effect has been found in chronic pelvic inflammatory disease. The review also revealed that balneotherapy has some beneficial effects on antioxidant status, and on metabolic and inflammatory parameters. Based on the results, we conclude that balneotherapy with Hungarian thermal-mineral waters is an effective remedy for lower back pain, as well as for knee and hand osteoarthritis.Entities:
Mesh:
Year: 2013 PMID: 23677421 PMCID: PMC3955132 DOI: 10.1007/s00484-013-0667-6
Source DB: PubMed Journal: Int J Biometeorol ISSN: 0020-7128 Impact factor: 3.787
Fig. 1Flowchart of the review and meta-analysis of randomised controlled trial (RCT) studies
Effect of balneotherapy on knee osteoarthritis. WOMAC Western Ontario and McMaster Universities index, RCT randomised controlled trial
| Trial | Study design | Internal validity score | Treatment |
| Outcome measures | Follow-up period | Results |
|---|---|---|---|---|---|---|---|
| Balint et al. | Double blind RCT | 7 | Group1: immersion in mineral water (34 °C) for 30 mins, 5 days a week for 4 weeks, as a 20-session treatment course | 27 | WOMAC activity, joint stiffness, pain and total score | 3 months | WOMAC activity, pain, and total scores improved significantly in the balneotherapy group and the difference remained significant at the end of the follow-up. The same parameters improved significantly also in the tap water group after balneotherapy, but this improvement was no longer detected at the end of the 3-month follow-up period |
| Group 2: the same as in the treatment group, but using heated tap water | 25 | ||||||
| Szucs et al. | Double blind RCT | 6 | Group 1: daily 20-min treatments in 36 °C thermal mineral water on 18 occasions | 30 | Number of patients with pain at baseline, erythrocyte sedimentation rate, white blood cell count | 3 weeks | Number of patients with pain at baseline, pain and tenderness decreased in the treatment group after treatment |
| Group 2: the same as in the treatment group, but using tap water | 32 | ||||||
| Kovacs and Bender | Double blind RCT | 7 | Group 1: bathing the painful knee in thermal mineral water cooled to 36 °C for 30 mins daily, over 15 days | 32 | Tenderness on palpation, overall ambulation capability, patient’s and physician’s rating of therapeutic effect, pain intensity (using VAS), range of motion, stair-climbing time | 15 weeks | All monitored parameters improved in both groups; however, the magnitude of the improvement was significantly greater in patients treated with thermal water |
| Group 2: the same as in Group 1, but using a mixture of tap water and thermal mineral water (36 °C) of negligible mineral content? | 25 | ||||||
| Gaal et al. | Prospective study | 3 | 15 balneotherapy sessions lasting 30 min each were administered daily, using 33-°C water | 38 | Changes in NSAID/analgesic consumption, VAS mean disease severity rated by the patients, doctor’s global assessment VAS score, the VAS of pain intensity, WOMAC scores, mean cumulative SF-36 (quality of life) scores | 10–14 weeks | All parameters improved significantly in both balneotherapy groups. The favourable effect was prolonged for 3 months after treatment |
Effect of balneotherapy on hand osteoarthritis. VAS Visual analogue scale, HAQ Health Assessment Questionnaire, SF-36 Short Form-36, AUSCAN Australian/Canadian Hand Osteoarthritis Index, EQ5D Euro Qol Group scores
| Trial | Study design | Internal validity score | Treatment |
| Outcome measures | Follow-up period | Results |
|---|---|---|---|---|---|---|---|
| Horvath et al. | Randomised, single blind, controlled trial | 9 | Group 1: head-out immersion in 38 °C thermal mineral water for 20 min, five times a week for 3 weeks and standard pulsed magnetic field therapy applied to the hands three times a week over 3 weeks | 21 | Pain in the joints of the hands at rest and upon exertion as rated by the patient, patient’s and physician’s global assessment, grip strength, pinch strength, HAQ, morning joint stiffness (min), swollen joint count, tender joint count, SF-36 | 13 weeks | Statistically significant improvement was observed in several studied parameters after treatment and during follow-up in the thermal water groups versus the control group |
| Group 2: the same as in Group 1, but using 36 °C thermal-mineral water | 21 | ||||||
| Group 3: pulsed magnetic field therapy | 21 | ||||||
| Kovacs et al. | Randomised, double blind, controlled trial | 8 | Group 1: head-out immersion for 20 min per session in a bath-tub filled with thermal mineral water, on 15 occasions altogether, over a period of 3 weeks. The temperature of the water was 37 °C. | 24 | Pain VAS, morning joint stiffness (min), grip strength, HAQ-DI, AUSCAN (total, pain, stiffness, physical function), EQ5D, EQVAS (quality of life) | 6 months | At the end of treatment, the improvement was more pronounced in the patient group treated with thermal mineral water. The difference between the groups was significant regarding pain VAS and EQVAS, both immediately and 3 months after treatment. The same was observed regarding AUSCAN after 3 months, as well as regarding HAQ after 3 and 6 months |
| Group 2: the same as in the treatment group, but in tap water of the same temperature | 21 |
Effect of balneotherapy on chronic low back pain
| Trial | Study design | Internal validity score | Treatment |
| Outcome measures | Follow-up period | Results |
|---|---|---|---|---|---|---|---|
| Tefner et al. | RCT single blind | 8 | 30-min-long balneotherapy sessions over 3 weeks, 5 days a week, using thermal-mineral water of 31 °C | 30 | VAS for pain at rest and on exertion, range of motion for the lumbar spine, Oswestry index, EuroQol-5D and SF-36 questionnaires | 15 weeks | In the treatment group, the mobility of the lumbar spine, the Oswestry index, the VAS scores, the EuroQoL-5D index, and most of the SF-36 items improved significantly on the short and on the long term |
| The same as in the treatment group, but using heated tap water | 27 | ||||||
| Kulisch et al. | RCT double blind | 9 | 20-min-long balneotherapy sessions daily over 3 weeks, using thermal-mineral water of 34 °C, add-on electrotherapy 3 times per week | 36 | VAS score of low back pain at rest and on exertion, VAS score by the patients, VAS score by the investigator, Schober’s sign, lateral flexion of the lumbar spine to the right (cm) and to the left (cm), (Domján sign), Oswestry’s Index, SF-36 | 13 weeks | There was a significant improvement in all parameters in the thermal water group after treatment and at follow up. The improvement in the control group was less substantial compared with baseline values. Comparison of the two treatments revealed a statistically significant difference in some outcome measures (doctor’s opinion, Schober’s sign, Oswestry’s Index after treatment, pain at rest, patients’ opinion, lateral flexion to the left at follow up) |
| The same as in the treatment group, but using heated tap water | 35 | ||||||
| Balogh et al. | RCT single blind | 7 | Daily 30-min baths in warm (36 °C) water on 15 consecutive days (except Sundays). | 26 | VAS score of low back pain, patient’s rating of efficacy, physician’s rating of efficacy, ability to perform activities of daily living, lifting, walking, standing, muscle spasm, paravertebral tenderness, flexion and extension of the spine, Schober’s sign, lateral flexion and rotation of the spine (measured with a goniometer), analgesic dose requirements | 3 month | Bathing in mineral water resulted in a statistically significant improvement reflected by the VAS, and manifested by the mitigation of muscle spasm, the alleviation of local tenderness, enhanced flexion-extension and rotation of the spine, as well as by the improvement of the Schober’s index after treatment. Hydrotherapy resulted only in temporary improvement of the VAS score |
| The same as in the treatment group, but in heated tap water | 30 | ||||||
| Konrad et al. | RCT | 5 | Group A: immersion in thermal mineral water (37 °C) | 35 | Number of analgesic tablets taken, VAS score of low back pain, spinal mobility, and the straight-leg raising sign | 12 month | Analgesic consumption and pain scores decreased significantly in all three treatment groups, with no differences between the groups. After 1 year, only analgesic consumption was significantly lower in the treated groups, compared with the control group |
| Group B: underwater traction bath in thermal mineral water (37 °C) | 44 | ||||||
| Group C: underwater massage in thermal mineral water (37 °C) for 15 min, three times a week, over 4 weeks | 26 | ||||||
| Control group: non-steroidal anti-inflammatory drugs only | 53 | ||||||
| Gaal et al. | Prospective study | 3 | 15 balneotherapy sessions lasting 30 min each, administered daily, at neutral water temperature (33–34 °C) | 38 | Number of patients taking NSAID/analgesic drugs, VAS mean disease severity rated by the patient, the Oswestry scores (%), mean cumulative SF-36 scores | 10–14 weeks | All monitored parameters were significantly improved by balneotherapy. The favourable effect was prolonged for 3 months after treatment |
Effect of underwater traction therapy on neck and lumbar pain
| Trial | Study design | Internal validity score | Inclusion criteria | Treatment |
| Outcome measures | Follow-up period | Results |
|---|---|---|---|---|---|---|---|---|
| Olah et al. | Controlled, non-randomised follow-up study | 4 | Subset A: lumbar pain caused by lumbar disc disease (demonstrated by MRI), radiating to the lower extremities | Group 1: McKenzie exercises for 20 min, electrotherapy with weight bath therapy | 18/18 | Lumbar pain (VAS), floor-finger distance, lateral flexion (cm), Oswestry Index, SF-36 | 3 months | Underwater cervical or lumbar traction resulted in significant improvement of all study parameters by the end of treatment, and it was still present 3 months later |
| Subset B: neck pain caused by cervical disc disease (demonstrated by MRI), radiating to the upper extremities | Group 2: McKenzie exercises for 20 min and electrotherapy (as Group 1) but without weight bath therapy | 18/18 | Cervical pain, lateral flexion, dorsal flexion, SF-36(quality of life) | Among the controls, significant improvement of just a single parameter was seen in patients with lumbar, and of two parameters in those with cervical disc disease |
Effect of balneotherapy on chronic inflammatory pelvic disease
| Trials | Study design | Internal validity score | Treatment |
| Outcome measures | Follow-up | Results |
|---|---|---|---|---|---|---|---|
| Zámbó et al. | Randomised, double blind | 6 | Daily baths of 20 mins (38.8 °C) on ten occasions | 20 | Pain (VAS) elicited by palpating the uterus, the adnexes and the parametrium, parametrial and adnexal mass; psychic status (VAS); ultrasound Doppler index | 3 weeks | In comparison with tap water, treatment with mineral water accomplished significantly greater improvement, as reflected by the relief of pain elicited by handling the uterus, and by the improvement of psychological status |
| The same as in treatment group, but using heated tap water | 20 |
Effect on endocrine parameters of exposure to radon in a spa bath and in healing caves
| Trials | Study design | Internal validity | Inclusion criteria | Treatment |
| Outcome measures | Follow-up | Results/response |
|---|---|---|---|---|---|---|---|---|
| Nagy et al. | Controlled, non–randomised, follow-up study | 1 | Any form of chronic respiratory disease, with the exception of acute exacerbations | Group 1: 4 h a day spent in the cave for 2 or 3 weeks (except weekends) during the summer period characterized by a high radon concentration | 46 | Thyroid stimulating hormone, free thyroxine, cortisol, prolactin, dehydroepiandrosterone sulphate, adrenocorticotrop hormone, and beta endorphine levels | 2 weeks | Significant decrease of cortisol levels, which was not directly correlated with radon concentration |
| Group 2: the same as in Group 1, but during the winter period characterized by a low radon concentration | 35 | Significant decrease of free thyroxine hormone level during the winter period | ||||||
| Nagy et al. | Controlled, non-randomised study | 5 | Patients with degenerative lesions of the spine and joints | Group 1: Fifteen balneotherapy sessions of 30 min duration were administered at the same time of the day at low radon concentration. Water temperature was 31 °C | 27 | Thyroid stimulating hormone, cortisol, prolactin, dehydroepiandrosterone sulphate, adrenocorticotrop hormone | 3 weeks | No significant differences between pre- and post-treatment values, or between the two patient groups |
| Joint and spinal diseases | Group 2: The same as in the treatment group, but at a negligible radon content. Water temperature was 32 °C | 25 |
Effect of balneotherapy on inflammatory and metabolic indices
| Trial | Study design | Internal validity score | Inclusion criteria | Treatment |
| Outcome measures | Follow-up period | Results |
|---|---|---|---|---|---|---|---|---|
| Bender et al. | Controlled trial | 5 | Subjects with chronic lumbar pain with a duration of at least 6 months; none had received balneotherapy in the preceding 3 months | Ten 30-min balneotherapy sessions over 2 weeks, 5 days a week, using thermal-mineral water of 34 °C | 10 | Catalase, glutathione peroxidase, malondialdehyde, and superoxide dismutase serum levels | 2 weeks | Balneotherapy with either of the two mineral waters significantly reduced the activity of all four enzymes studied compared to the controls |
| Group 1 at Cserkeszőlő and Group 2 at Mórahalom | 10 | |||||||
| Group 3: the same as in the treatment groups, but using heated tap water | 10 | |||||||
| Holló et al. | Prospective, non–randomised, controlled trial | 2 | Outpatients with extensive psoriatic skin involvement | Narrow-band UV B light therapy combined with simultaneous bathing in 10 % Dead Sea salt solution five times a week, up to a total of 35 sessions | 12 | Plasma β-endorphin level | 7 weeks | There was no significant change in the plasma levels of beta-endorphin after the clinical clearance of psoriatic skin lesions |
| Olah et al. | Double blind, controlled, follow-up study | 7 | Outpatients with degenerative musculosceletal disorders treated with balneotherapy for any reason | Group 1: 30-min balneotherapy sessions on 15 occasions, five times per week using thermal-mineral water of 38 °C | 21 | HSP-60, TAS (total antioxidant status), CRP, cholesterol, LDL/HDL ratio, triglyceride, LDL, HDL | 15 weeks | No significant difference between the groups |
| Group 2: the same as in the treatment group, but using tap water with imitated colour and the same temperature | 21 | |||||||
| Olah et al. | Randomised, controlled trial with follow-up | 6 | Subset ‘A’: 44 overweight and obese patients with a body mass index (BMI) of >25 kg/m2 | Group 1: Balneotherapy with 38 °C thermal water on 5 occasions per week, in 15 sessions of 30 min each | 22/22 | Cholesterol, triglyceride, HDL-C, LDL-C, glucose, HbA1c, fructosamine, iron, transferrin, ferritin, CRP, TAS, coeruloplasmin, albumin, β2 microglobulin, bilirubin, uric acid, NAG, cystatin C, NO2 | 15 weeks | In obese patients, haemoglobin A1C level decreased in both groups, otherwise there was no difference between the groups |
| Subset ‘B’: Non-overweight hypertensive patients | Group 2: The subjects simply continued on their pre-existing drug therapy | 22/20 | In hypertensive patients, differences could be detected between baseline and post-treatment haemoglobin A1C levels in both groups, the change of which was significantly greater in the balneotherapy group | |||||
| In hypertensive patients, CRP levels decreased significantly after balneotherapy |
Fig. 2Visual analogue scale (VAS) intensity of pain on loading
Fig. 3VAS intensity of pain at rest